Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Ipilimumab – Benefit assessment according to § 35a Social Code Book V. Dossier assessment; Commission A12-07. April 27, 2012. (IQWiG reports; Volume 130).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Ipilimumab (new therapeutic indication) – Benefit assessment according to § 35a Social Code Book V. Dossier assessment; Commission: A13-44. March 13, 2014. (IQWiG reports; Volume 209).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Addendum to Commission A13-44 (Ipilimumab, new therapeutic indication). Commission A14-11. March 26, 2014. (IQWiG reports; Volume 213).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). 2. Addendum to Commission A13-44 (Ipilimumab, new therapeutic indication). CommissionA14-15. May 16, 2014. (IQWiG reports; Volume 223).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Ipilimumab (melanoma) – Benefit assessment according to § 35a Social Code Book V. Dossier assessment; Commission A18-12. May 09, 2018. (IQWiG reports; Volume 626).
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Ipilimumab (melanoma) – Benefit assessment according to § 35a Social Code Book V. Dossier assessment; Commission A18-44. September 27, 2018. (IQWiG reports; Volume 669).
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.